Cystic fibrosis transmembrane conductance regulator gene abnormalities in patients with asthma and recurrent neutrophilic bronchitis

Canadian Respiratory Journal

Volumn 19, Issue 1, 2012, Pages 46-48

  Goodwin, Jodi ^a   Spitale, Naomi ^a   Yaghi, Asma ^a   Dolovich, Myrna ^a   Nair, Parameswaran ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Asthma; CFTR gene mutations; Neutrophilic bronchitis; Sputum

Indexed keywords

IMMUNOGLOBULIN E; METHACHOLINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; BRONCHIECTASIS; BRONCHITIS; CASE REPORT; CELL COUNT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; FEMALE; GENE MUTATION; HUMAN; LUNG FUNCTION; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RECURRENT DISEASE; RECURRENT NEUTROPHILIC BRONCHITIS; SPIROMETRY; SPUTUM ANALYSIS; SPUTUM CULTURE;

EID: 84860506911     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/546702     Document Type: Article

References (23)

1. Rommens JM, Iannuzzi MC, Kerem B, et al. Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 1989;245:1059-65. (Pubitemid 19231813)
2. Collins FS. Cystic fibrosis: Molecular biology and therapeutic implications. Science 1992;256:774-9.
3. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168:918.
4. Cystic Fibrosis Mutation Database 〈www.genet.sickkids.on. ca〉(Accessed on September 9, 2010).
5. Mehta A, Bush A. Beyond chloride transport: CFTR in the 21st century. Pediatr Pulmonol 2005;39:289-91.
6. Noone PG, Knowles, MR. 'CFTR-opathies': Disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations. Respir Res 2001;2:328-32. (Pubitemid 34189660)
7. Nair P, Hargreave FE. Measuring bronchitis in airway diseases: Clinical implementation and application. Chest 2010;138:38S-43S.
8. Ip W, Turner D, Han WS, Rose J, Durie P, Quinton P. Sweat gland bioelectrics differ in cystic fibrosis: A new concept for potential diagnosis and assessment of CFTR function in cystic fibrosis. Thorax 2009;64:932-8.
9. Farrell PM, Rosenstein BJ, White TB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. Guidelines for diagnosis of cystic fibrosis in newborns through older adults. J Pediatr 2008;153:S4-S14. (Pubitemid 351970581)
10. Dolovich MB, Mahony JB, Chambers C, Newhouse MT, Chernesky MA. Ciliary function, cell viability, and in vitro effect of ribavirin on nasal epithelial cells in acute rhinorrhea. Chest 1992;102:284-7.
11. De Cid, R, Chomel JC, Lazaro C et al. CFTR and asthma in the French EGEA study. Eur J Hum Genet 2001:9;67-9. (Pubitemid 32124438)
12. Schroeder SA, Gaughan DM, Swift M. Protection against bronchial asthma by CFTR delta F508 mutation: A heterozygote advantage in cystic fibrosis. Nat Med 1995;1:703-5.
13. Dahl M, Tybjaerg-Hansen, A, Lange, P, Nordestgaard, BG. Delta F508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet 1998;351:1911-3. (Pubitemid 28297446)
14. Lowenfels AB, Maisonneuve P, Palys B, Schoni MH, Redemann B. Delta F508 heterozygosity and asthma. Lancet 1998;352:985.
15. Douros K, Loukou I, Doudounakis S, Tzetis M, Priftis KN, Kanavakis E. Asthma and pulmonary function abnormalities in heterozygotes for cystic fibrosis transmembrane regulator gene mutations. Int J Clin Exp Med 2008:1;345-9.
16. Ziedalski TM, Kao PN, Henig NR, Jacobs SS, Ruoss SJ. Prospective analysis of cystic fibrosis and transmembrance regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection. Chest 2006;130:1995-1002.
17. Davis PB. Pathophysiology of the lung disease in cystic fibrosis. New York: Marcel Dekker, 1993:193.
18. Michoud MC, Robert R, Hassan M, et al. Role of the cystic fibrosis transmembrane conductance channel in human airway smooth muscle. Am J Respir Cell Mol Bio 2008;40:217-22.
19. Chang AB, Redding GJ, Everard ML. Chronic wet cough: Protracted bronchitis, chronic suppurative lung disease and bronchiectasis. Pediatr Pulmonol 2008;43:519-31. (Pubitemid 351813004)
20. Marchant JM, Gibson PG, Grissell TV, Timmins NL, Masters IB, Chang A. Prospective assessment of protracted bacterial bronchitis: Airway inflammation and innate immune activation. Pediatr Pulmonol 2008;43:1092-9.
21. Elkins MR, Robinson M, Rose BR, et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006;354:229-40. (Pubitemid 43113028)
22. Wills P, Greenstone M. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev 2006;2:CD002996.
23. Thomas B, Rutman A, Hirst RA, et al. Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma. J Allergy Clin Immunol 2010;126:722-9.e2.